Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation. Cara possesses both near-term clinical development opportunities combined with proprietary...
Total money raised: $38.7M
One Parrott Drive
Board of Directors
Cara Therapeutics raised $15M in a Series D round from Rho Capital Partners, Alta Partners, Connecticut Innovations, MVM Life Science Partners, Mitsubishi Corporation, Scottish Widows Investment Partnership, Ascent Biomedical Ventures, and Devon Park BioVentures
Cara rounds up $15M for post-op pain drug Read more: Cara rounds up $15M for post-op pain drug fiercebiotech.com
Cara Therapeutics raised $19M in a Series C round from MVM Life Science Partners, Alta Partners, and Ascent Biomedical Ventures
Cara Therapeutics raised $4.7M in a Series B round from Ascent Biomedical Ventures and Esperante Ventures